© 2024 Intra-Cellular Therapies Inc. All rights reserved.
SEC Filing Details
Document Details
Form
Filing Date
Oct 16, 2020
Document Date
Oct 15, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Intra-Cellular Therapies Inc.
Issuer
INTRA-CELLULAR THERAPIES, INC.
Filer
Neumann Mark